Evolution of the Average Target: London Stock Exchange Group Plc

Evolution of the Target Price: London Stock Exchange Group Plc

Changes in Analyst Recommendations: London Stock Exchange Group Plc

2baf43a1087.quvJIMCqWI9rhF9TwvgoTkG4LFY86b9A8YRgf2PcY0g.m5Kda4veG7w__mwEjctyPHSMQAJypvcjpM0EPiWvUwv4xpZH7cA63R3HHg~6de23d5f8f3534abecf7c8ab21882f48
09:48am Deutsche Bank Research raises Relx to 'buy' AN
06:31am LONDON STOCK EXCHANGE : JP Morgan remains its Buy rating ZD
11-25 LONDON STOCK EXCHANGE : Receives a Buy rating from JP Morgan ZD
11-21 AlphaValue/Baader Europe Upgrades London Stock Exchange Group to Buy, Lowers PT MT
11-13 Gene therapy developer Neurogene's Q3 net loss widens RE
11-13 Fennec Pharmaceuticals Q3 product sales rise RE
11-12 DiaMedica Therapeutics' Q3 net loss widens RE
11-12 Canadian gold miner Orezone misses Q3 adjusted EPS expectations RE
11-12 Crescent Capital's Q3 NAV per share falls RE
11-12 Cisco Q1 revenue beats estimates, raises annual revenue forecast RE
11-12 Cancer diagnostics firm Celcuity posts smaller-than-expected Q3 adjusted loss per share  RE
11-12 Menswear maker Jerash Holdings Q2 revenue beats estimates RE
11-12 Biotech royalty aggregator XOMA reports Q3 net income of $14.1 mln RE
11-12 Globalfoundries Q3 revenue slightly edges expectations on auto, communications markets demand  RE
11-12 TScan Therapeutics Q3 revenue jumps RE
11-12 Unicycive Therapeutics Q3 net loss widens to $6 mln RE
11-12 African online retailer Jumia's Q3 revenue up 25% RE
11-12 LONDON STOCK EXCHANGE : UBS reiterates its Buy rating ZD
11-12 BofA Keeps UK's LSEG at Buy Amid Higher Growth Potential for Data & Analytics Business MT
11-11 Chemtrade Logistics Income Fund Q3 revenue beats expectations RE
11-11 True North Commercial REIT Q3 revenue rises slightly, NOI down 5% RE
11-11 Invesco preliminary AUM rises 2% in October to $2.167 trillion RE
11-11 QuickLogic Q3 revenue down nearly 52% RE
11-11 Robotic surgery firm Stereotaxis's Q3 net loss widens RE
11-11 LONDON STOCK EXCHANGE : Deutsche Bank reaffirms its Buy rating ZD
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+45.29%
+21.18%
+23.02%
+14.85%
+16.42%
+15.6%
+0.15%
+10.4%
+21.9%
+2.62%
Average +17.14%
Weighted average by Cap. +21.96%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
85.00GBP
Average target price
123.49GBP
Spread / Average Target
+45.29%
High Price Target
137.90GBP
Spread / Highest target
+62.24%
Low Price Target
110.00GBP
Spread / Lowest Target
+29.41%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

JPMORGAN Enrico Bolzoni
AlphaValue/Baader Europe
UBS Michael Werner
RBC Ben Bathurst
alphavalue Sylvain Perret
GOLDMAN SACHS Oliver Carruthers
DEUTSCHE BANK RESEARCH Benjamin Goy
JEFFERIES Tom Mills
Autonomous Research
BNP Paribas
Morningstar
Deutsche Bank Securities
Kepler Cheuvreux
ODDO BHF
Jefferies & Co.
Berenberg Bank
Morgan Stanley
RBC Capital Markets
Citigroup
Credit Suisse
Barclays
DEUTSCHE BANK Benjamin Goy
HSBC
BERENBERG Peter Richardson
Bank of America Securities/Merrill Lynch
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
85.00GBP
Average target price
123.49GBP
Spread / Average Target
+45.29%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. LSE Stock
  4. Consensus London Stock Exchange Group Plc